Blog
RSS FeedPosted by Michael Wonder on 18 Feb 2025
We could be paying too much for knee and hip replacements
18 February 2025 - As more baby boomers have their joints replaced and the population struggles with obesity, we need to ...
Posted by Michael Wonder on 17 Feb 2025
Unravelling the association between uncertainties in model-based economic analysis and funding recommendations of medicines in Australia
14 February 2025 - Health technology assessment is used extensively by the PBAC to inform medicine funding recommendations in Australia. ...
Posted by Michael Wonder on 10 Feb 2025
Big pharma steps up push for taxpayer-funded weight loss drugs
9 February 2025 - Novo Nordisk and Eli Lilly have asked the federal government to list their blockbuster weight-loss drugs ...
Posted by Michael Wonder on 09 Feb 2025
Albanese Labor Government strengthening Medicare with over $500 million for women's health
9 February 2025 - The Albanese Labor Government is building Australia’s future and strengthening Medicare, today announcing $573.3 million to deliver ...
Posted by Michael Wonder on 02 Feb 2025
Public consultation: draft 2025-26 cost recovery implementation statement for listing medicines on the PBS and designated vaccines on the NIP
31 January 2025 - Consultation on the draft 2025-26 cost recovery implementation statement for listing medicines on the PBS and ...
Posted by Michael Wonder on 02 Feb 2025
Cheaper medicine for lung cancer patients
2 February 2025 - The Australian Government is listing Retevmo (selpercatinib) on the PBS for the first time to treat advanced ...
Posted by Michael Wonder on 01 Feb 2025
Bupa and Healthscope end battle over hospital payments, meaning no gap fees for stays
31 January 2025 - Millions of Bupa customers will avoid incurring gap fees for stays at Healthscope hospitals after the ...
Posted by Michael Wonder on 01 Feb 2025
Schedule of Pharmaceutical Benefits - 1 February 2025
1 February 2025 - The February 2025 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 Jan 2025
Outcomes from the December 2024 PBAC meeting
31 January 2025 - Recommendations made by the PBAC in December 2024 relating to the listing of medicines on the PBS ...
Posted by Michael Wonder on 29 Jan 2025
Von Hippel-Lindau disease drug Welireg listed on PBS slashing cost by $11,000 a month for patients
28 January 2025 - The treatment for Simon Goodrich’s disease has been costing $12,000 a month, but there has been a ...
Posted by Michael Wonder on 28 Jan 2025
Apellis receives approval of Syfovre (pegcetacoplan) in Australia for geographic atrophy
27 January 2025 - Apellis Pharmaceuticals announced today that the TGA has approved Syfovre (pegcetacoplan) for the every-other-month treatment of adult ...
Posted by Michael Wonder on 24 Jan 2025
Australia’s TGA approves registration of CSL’s Andembry (garadacimab) for the prevention of recurrent hereditary angioedema attacks
24 January 2025 - This regulatory approval for registration in Australia is the first in the world for Andembry. ...
Posted by Michael Wonder on 21 Jan 2025
Drug shortage crisis demands intervention, AMA warns, as patients struggle to secure medicines
20 January 2025 - There are more than 400 medicine shortages, and the country’s leading medical group blames it on ‘ad ...
Posted by Michael Wonder on 20 Jan 2025
Australians benefit from freeze to maximum cost of PBS medicines
20 January 2025 - The Australian Government has launched an advertising campaign to raise awareness about a freeze on the maximum ...
Posted by Michael Wonder on 19 Jan 2025
Protection against RSV for mums and bubs with free vaccine available from 3 February
19 January 2025 - From 3 February 2025, Australian mums and their newborn babies will have free access to the best ...